Renal Cancer - Results from #2560

Exelixis Announces Submission of Supplemental New Drug Application to U.S. Food and Drug Administration for CABOMETYX® (cabozantinib) in Combination With Opdivo® (nivolumab) for Advanced Renal Cell Carcinoma August 24, 2020

Angiogenic and immune-related biomarkers and outcomes following axitinib/pembrolizumab treatment in patients with advanced renal cell carcinoma. August 24, 2020

Features of increased malignancy in eosinophilic clear cell renal cell carcinoma. August 24, 2020

LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma. August 24, 2020

Is lymph node dissection necessary for staging while undergoing nephrectomy in patients with renal cell carcinoma? August 21, 2020

Renal Cell Tumors: Uncovering the Biomarker Potential of ncRNAs. August 21, 2020

FOXI1 expression in chromophobe renal cell carcinoma and renal oncocytoma: a study of The Cancer Genome Atlas transcriptome-based outlier mining and immunohistochemistry. August 21, 2020

Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancer. August 20, 2020

Shape and texture-based radiomics signature on CT effectively discriminates benign from malignant renal masses. August 20, 2020

Adjuvant instant preoperative renal artery embolization facilitates the radical nephrectomy and thrombectomy in locally advanced renal cancer with venous thrombus: a retrospective study of 54 cases. August 20, 2020

Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma. August 19, 2020

ARCHITECT® urine-neutrophil gelatinase-associated lipocalin (u-NGAL) assay as new prognostic marker for clear cell Renal Cell Carcinoma (ccRCC) (preliminary results). August 19, 2020

Lexicon for renal mass terms at CT and MRI: a consensus of the society of abdominal radiology disease-focused panel on renal cell carcinoma. August 19, 2020

Outcomes of complete metastasectomy in metastatic renal cell carcinoma patients: The Canadian Kidney Cancer information system experience. August 18, 2020

Elevated Pre-operative C-reactive Protein Is Associated with Renal Functional Decline and Non-Cancer Mortality in Surgically Treated Renal Cell Carcinoma: Analysis from the INternational Marker Consortium for Renal Cancer [INMARC]. August 18, 2020

Prevalence of pathogenic variants in DNA damage response and repair genes in patients undergoing cancer risk assessment and reporting a personal history of early-onset renal cancer. August 18, 2020

A novel circRNA, circNUP98, a potential biomarker, acted as an oncogene via the miR-567/ PRDX3 axis in renal cell carcinoma. August 17, 2020

Cabozantinib in advanced renal cell carcinoma: A phase II, open-label, single-arm study of Japanese patients. August 17, 2020

Construct a circRNA/miRNA/mRNA regulatory network to explore potential pathogenesis and therapy options of clear cell renal cell carcinoma. August 17, 2020

SPARC is a key mediator of TGF-β-induced renal cancer metastasis. August 14, 2020

Page 129 of 456